```html

Bronchopulmonary Dysplasia (BPD)

Overview

Bronchopulmonary dysplasia (BPD) is a chronic lung disease that primarily affects premature infants who required mechanical ventilation and oxygen therapy after birth. The condition involves inflammation and scarring of the lung tissue, leading to impaired gas exchange and long‑term respiratory problems.

Who it affects: Most cases occur in infants born before 32 weeks gestation, especially those with very low birth weight (<1500 g). Although BPD is rare in full‑term children and adults, some people who had BPD as infants may experience lingering airway obstruction into adolescence and adulthood.

Prevalence: In the United States, BPD affects roughly 10–15 % of infants born before 28 weeks gestation and about 30 % of those born before 24 weeks [1]. Worldwide, the incidence varies with the level of neonatal intensive care; in high‑income countries the rate is 10–20 % of very‑preterm births, while low‑ and middle‑income countries report higher rates due to limited ventilatory support and infection control [2].

Symptoms

Symptoms can range from mild to severe and may evolve as the child grows. Common manifestations include:

• Rapid, shallow breathing (tachypnea) – especially noticeable during feeding or activity.
• Chronic cough – often dry but may become productive if infections develop.
• Wheezing or whistling sounds – due to narrowed airways.
• Retractions – visible pulling in of the chest muscles between ribs or under the ribcage during inhalation.
• Frequent respiratory infections – including bronchiolitis and pneumonia.
• Oxygen desaturation – drops in blood oxygen levels, sometimes requiring supplemental oxygen at home.
• Failure to thrive – poor weight gain caused by increased work of breathing.
• Apnea episodes – brief pauses in breathing, more common in the first months of life.
• Exercise intolerance – children may tire quickly during play.

In older children and adolescents, symptoms may mimic asthma, with episodic wheeze and shortness of breath, but they often respond less well to typical asthma medications.

Causes and Risk Factors

BPD does not have a single cause. It results from a combination of prenatal, perinatal, and postnatal factors that damage the immature lung.

Primary contributors

• Premature birth – lungs are under‑developed (the alveolar stage begins around 24 weeks gestation).
• Mechanical ventilation – high airway pressures and volumes can cause barotrauma and volutrauma.
• Prolonged exposure to supplemental oxygen – oxygen toxicity leads to inflammation and fibrosis.
• Infection – prenatal (chorioamnionitis) or postnatal (sepsis, ventilator‑associated pneumonia) increase inflammatory injury.
• Inflammatory mediators – cytokines released during infection or ventilation damage the delicate alveolar-capillary membrane.

Risk factors

• Gestational age < 28 weeks
• Birth weight < 1500 g (especially < 1000 g)
• Male sex (slightly higher risk)
• Maternal smoking or exposure to pollutants during pregnancy
• Genetic predisposition to abnormal lung development
• Prolonged use of high‑frequency oscillatory ventilation (HFOV) or continuous positive airway pressure (CPAP) with high pressures
• Delayed or inadequate administration of antenatal steroids

Diagnosis

Diagnosing BPD involves a combination of clinical assessment, imaging, and functional testing. The most widely used definition (NICHD, 2001) categorizes BPD based on the need for supplemental oxygen at 36 weeks post‑menstrual age (PMA) or at discharge.

Diagnostic steps

1. Clinical observation – persistent respiratory distress, need for oxygen, and history of mechanical ventilation.
2. Chest radiography – may show hyperinflated lungs, atelectasis, or diffuse interstitial markings.
3. Chest CT (if needed) – provides detailed view of airway remodeling and fibrosis, useful for research or severe cases.
4. Pulse oximetry – continuous monitoring of oxygen saturation; persistent SpO₂ < 90 % without supplemental O₂ suggests significant disease.
5. Blood gases – arterial or capillary samples to assess CO₂ retention and acid‑base status.
6. Pulmonary function testing (PFT) – performed after 6 months of age; shows reduced forced expiratory volume (FEV₁) and increased airway resistance.
7. Echocardiography – screens for pulmonary hypertension, a common complication.

When a newborn meets the oxygen‑requirement criteria at 36 weeks PMA, the diagnosis of BPD is confirmed.

Treatment Options

Management aims to minimize lung injury, support breathing, and prevent infection. Treatment is individualized based on severity.

Medications

• Diuretics (e.g., furosemide) – reduce pulmonary edema and improve lung compliance.
• Corticosteroids – systemic (e.g., dexamethasone) for severe BPD, short courses to reduce inflammation; inhaled steroids may be used for milder disease.
• Bronchodilators (β2‑agonists) – alleviate airway obstruction; often combined with inhaled steroids.
• Pulmonary vasodilators (e.g., sildenafil) – for associated pulmonary hypertension.
• Antibiotics – targeted therapy for bacterial infections; prophylactic azithromycin has been studied for anti‑inflammatory effects.

Ventilatory support

• Supplemental oxygen – low‑flow nasal cannula, heated humidified high‑flow systems, or long‑term oxygen (LTO) devices for home use.
• Non‑invasive ventilation – CPAP or NIPPV to reduce work of breathing while avoiding intubation.
• Mechanical ventilation – used only when absolutely necessary; lung‑protective strategies (low tidal volume 4–6 mL/kg, permissive hypercapnia) are essential.

Procedures

• Tracheostomy – considered for infants who remain ventilator‑ dependent beyond 3–6 months.
• Surfactant therapy – early administration improves outcomes; repeated dosing may be used in some cases.

Lifestyle and supportive care

• Optimized nutrition (high‑calorie, protein‑rich feeds) to promote growth.
• Daily physiotherapy and gentle chest percussion to aid mucus clearance.
• Environmental control – smoke‑free home, avoidance of indoor pollutants.
• Vaccinations – influenza, RSV prophylaxis (palivizumab) for high‑risk infants.

Living with Bronchopulmonary Dysplasia

Families often worry about the long‑term outlook. While BPD can be lifelong, many children improve with age, especially with aggressive early management.

Daily management tips

• Monitor oxygen saturation regularly with a pulse oximeter; keep SpO₂ > 90 % (or your provider’s target).
• Adhere to medication schedules – use spacers for inhaled meds, and keep a medication log.
• Keep airways clear – saline drops, gentle suctioning, and humidified air help.
• Nutrition – offer frequent, calorie‑dense feeds; consider fortified breast milk or specialized formulas.
• Physical activity – encourage age‑appropriate play; gradual increase in activity improves lung capacity.
• Regular follow‑up – pulmonology, cardiology (for pulmonary hypertension), and developmental assessments every 3–6 months in early years.
• School planning – provide the school nurse with the child’s oxygen equipment and emergency action plan.
• Family support – join support groups (e.g., March of Dimes, BPD Foundation) for emotional and practical advice.

Prevention

Because BPD stems from prematurity and iatrogenic injury, prevention focuses on reducing preterm birth and minimizing lung trauma.

• Antenatal care – maternal smoking cessation, infection screening, and optimal nutrition.
• Antenatal corticosteroids – administered to women at risk of delivery before 34 weeks; reduces incidence of respiratory distress syndrome and BPD [3].
• Gentle ventilation strategies – use of CPAP instead of intubation when possible, low‑volume ventilation, and early extubation protocols.
• Oxygen targeting – maintain SpO₂ 90–95 % to avoid hyperoxia.
• Infection control – hand hygiene, aseptic techniques, and early treatment of neonatal sepsis.
• Nutrition optimization – early enteral feeding supports lung growth.

Complications

If BPD is severe or poorly controlled, several serious complications can arise:

• Pulmonary hypertension – occurs in up to 25 % of severe BPD cases; can lead to right‑heart failure.
• Growth failure – chronic illness and increased caloric needs often cause weight and height deficits.
• Neurodevelopmental delay – linked to prolonged hypoxia and hospitalisation.
• Recurrent respiratory infections – higher hospitalization rates for bronchiolitis and pneumonia.
• Chronic lung disease in adulthood – reduced lung function, increased risk of COPD‑like symptoms.
• Airway remodeling and wheezing – may mimic or coexist with asthma.

When to Seek Emergency Care

References

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine. 2001;163(7):1723‑1729. PMID: 11378171.
2. Rheude B, Stoll BJ, Little M. Global burden of preterm‑related bronchopulmonary dysplasia. World Health Organization Technical Report Series. 2022.
3. American College of Obstetricians and Gynecologists. Antenatal corticosteroid therapy: ACOG Practice Bulletin No. 212. 2020.
4. National Heart, Lung, and Blood Institute. Neonatal Chronic Lung Disease. NIH, 2023. https://www.nhlbi.nih.gov/health-topics/bronchopulmonary-dysplasia
5. Mayo Clinic. Bronchopulmonary dysplasia (BPD) – Symptoms and causes. 2024. https://www.mayoclinic.org/
6. Cleveland Clinic. BPD in infants – Diagnosis and treatment. 2023. https://my.clevelandclinic.org/

```